市場調査レポート

商品コード

1533633

3Dバイオプリンティングの市場規模、シェア、成長分析：コンポーネント別、材料別、技術別、地域別 - 産業予測、2024年～2031年

3D Bioprinting Market Size, Share, Growth Analysis, By Component (3D Bioprinters, Bioinks), By Material (Living Cell, Hydrogel), By Technology (Inkjet-based, Magnetic Levitation), By Region - Industry Forecast 2024-2031

出版日: 2024年08月09日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 760,921円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 890,134円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,019,347円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=143.57円

全表示
概要
目次

概要

サンプル依頼リストに入れる

世界の3Dバイオプリンティングの市場規模は、2022年に10億8,000万米ドルとなり、2023年の13億米ドルから、2031年までには59億2,000万米ドルに成長し、予測期間（2024年～2031年）のCAGRは20.8%で成長する見通しです。

臓器移植市場の成長の促進力は、臓器提供者の不足と慢性呼吸器疾患を抱える高齢化です。研究開発への投資の増加、技術の進歩、慢性疾患の有病率の上昇が、予測期間中の市場拡大に拍車をかけると見られています。3Dプリンティングは、移植用の腎臓、心臓、肺などの複雑な臓器を製造できることから、医療分野で重要性を増しています。レシピエントの体による拒絶反応のリスクがある従来の臓器移植とは異なり、3Dプリント臓器は患者自身の血液に由来する細胞を使用するため、拒絶反応のリスクが軽減されます。この技術は、新しい臓器の作成や骨折した骨の修復を可能にし、医療において大きな期待が寄せられています。さらに、3Dバイオプリンティングは、失った脚の代わりとなる義肢の製造を可能にし、ドナーの臓器を必要とする従来の方法に比べ、より迅速で効率的な代替手段を提供します。臓器に対する高い需要と限られたドナー数との間の格差は、移植までの待ち時間を長くしています。この課題に対処するため、科学者たちは人工臓器の開発に取り組んでいます。しかし、現在の人工臓器はまだヒトへの移植には適していません。この需要と供給のギャップが、3Dプリンターによる臓器の開発を推進し、臓器移植分野における商業的なアンメット・ニーズを満たすことを目指しています。

市場概要
3Dバイオプリンター
- マイクロ押し出しバイオプリンター
- インクジェット3Dバイオプリンター
- レーザー支援バイオプリンター
- ステレオリソグラフィーベースのバイオプリンター
- 磁気3Dバイオプリンター
- その他
バイオインク
- 天然バイオインク
- ハイブリッドバイオインク
- 合成バイオインク
ソフトウェア
消耗品

3Dバイオプリンティング市場：材料別

市場概要
生細胞
ハイドロゲル
細胞外マトリックス
その他

3Dバイオプリンティング市場：用途別

市場概要
調査用途
- 医薬品調査
- 再生医療
- 3D細胞培養
臨床応用
- 肌
- 骨・軟骨
- 血管
- その他

3Dバイオプリンティング市場：技術別

市場概要
磁気浮上
インクジェットベース
注射器ベース
レーザーベース
その他

3Dバイオプリンティング市場：エンドユーザー別

市場概要
学術・研究機関
製薬・バイオテクノロジー企業
病院

3Dバイオプリンティング市場規模：地域別

市場概要
北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- イタリア
- 英国
- その他欧州地域
アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域

競合情勢

上位5社の比較
主要企業の市場ポジショニング（2023年）
主要な市場企業が採用した戦略
市場における最近の活動
主要企業の市場シェア（2023年）

主要企業プロファイル

Organovo Holdings, Inc.（US）
3D Systems, Inc.（US）
CELLINK AB（Sweden）
Stratasys Ltd.（US）
Rokit Healthcare（Korea）
Poietis SAS（France）
Aspect Biosystems Ltd.（Canada）
Cyfuse Biomedical K.K.（Japan）
Tissuelabs（Switzerland）
Advanced Solutions, Inc.（US）
RegenHU Ltd.（Switzerland）
Materialise NV（Belgium）
Microdrop Technologies GmbH（Germany）
GeSiM mbH（Germany）
3D Biotek, LLC（US）
REGEMAT 3D, SL（Spain）
POIETIS（France）
SUNP BIOTECH（China）
MEDPRIN（China）
PRODWAYS（France）

Product Code: SQMIG20I2072

Global 3D Bioprinting Market size was valued at USD 1.08 Billion in 2022 and is poised to grow from USD 1.3 Billion in 2023 to USD 5.92 Billion by 2031, growing at a CAGR of 20.8% in the forecast period (2024-2031).

The growth of the organ transplantation market is driven by a shortage of organ donors and an aging population with chronic respiratory diseases. Increased investment in research and development, technological advancements, and the rising prevalence of chronic illnesses are expected to fuel market expansion over the forecast period. 3D printing is gaining significance in the medical field for its ability to produce complex organs such as kidneys, hearts, and lungs for transplants. Unlike traditional organ transplants, which risk rejection by the recipient's body, 3D-printed organs use cells derived from the patient's own blood, reducing the risk of rejection. This technology holds great promise in medicine, allowing for the creation of new organs and the repair of fractured bones. Moreover, 3D bioprinting enables the production of prosthetic limbs to replace lost legs, offering a faster and more efficient alternative compared to traditional methods that require donor organs. The disparity between the high demand for organs and the limited number of donors results in longer waiting times for transplants. To address this challenge, scientists are working on developing synthetic organs. However, current synthetic organs are not yet suitable for human transplantation. This gap between demand and supply is driving the advancement of 3D-printed organs, aiming to meet the unmet commercial needs in the field of organ transplantation.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global 3D Bioprinting market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global 3D Bioprinting Market Segmental Analysis

Global 3D bioprinting market is segmented based on Component, Material, Application, Technology, End-user, and Region. Based on Component, the market is segmented into 3D Bioprinters (Micro Extrusion Bioprinters, Inkjet 3d Bioprinters, Laser-assisted Bioprinters, Stereolithography-based Bioprinters, Magnetic 3d Bioprinters, Other), Bioinks (Natural Bioinks, Hybrid Bioinks, Synthetic Bioinks), Software, And Consumables. Based on Material, the market is segmented into liVing Cells, Hydrogels, Extracellular Matrices, And Other. Based on Application, the market is segmented into Research Applications (Drug Research, Regenerative Medicine, 3d Cells Culture), And Clinical Applications (Skin, Bone & Cartilage, Blood Vessels, Other). Based on Technology, the market is segmented into Magnetic Levitation, Inkjet-based, Syringe-based, Laser-based, And Others. Based on End-user, the market is segmented into Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, And Hospitals. Based on region, the market is segmented into North America, Europe, Asia-Pacific, Middle East and Africa, and Latin America.

Drivers of the Global 3D Bioprinting Market

Pharmaceutical companies are increasingly adopting 3D bioprinting technologies to enhance the discovery and development of new medications. Unlike traditional drug testing methods, 3D bioprinting offers a more cost-effective and safer alternative. This technology significantly accelerates the drug testing process, enabling pharmaceutical firms to evaluate a drug within hours rather than the three to six years typically required for new drug development. By using 3D-printed tissues, research and development teams can conduct early testing and preclinical trials more efficiently. The advantages of 3D bioprinting include reduced reliance on animal testing, improved productivity, and a faster drug development timeline. Additionally, the growing application of 3D printing in the cosmetic industry is contributing to market expansion. Since March 2013, the European Commission has prohibited animal testing for cosmetics. In response, some cosmetics and healthcare companies have turned to 3D bioprinting to create innovative 3D tissue models and develop new drug screening techniques, further driving the growth of this technology.

Restraints in the Global 3D Bioprinting Market

The high cost of equipment and bioinks necessary for producing functional tissues and organs presents a significant challenge for research institutions and medical facilities seeking to adopt and integrate 3D bioprinting technologies. Additionally, the complexity of the procedures and the need for skilled personnel further increase operational costs. These factors limit the widespread adoption and growth of 3D bioprinting. Consequently, the high expenses and technical barriers are restraining the expansion of the 3D bioprinting market.

Market Trends of the Global 3D Bioprinting Market

Burns and scars, especially on visible parts of the body, can significantly affect an individual's appearance. As consumer awareness of personal appearance rises, there is a growing demand for dermal surgeries and treatments worldwide. According to the National Institute on Aging, a substantial portion of individuals aged 16 to 33 is increasingly adopting advanced dermatological solutions. This trend is creating substantial opportunities for manufacturers of related products. The rising focus on self-care is a key driver behind the expansion of the 3D bioprinting market in developed regions. Additionally, 3D bioprinting technology is playing a crucial role in healthcare by facilitating the bioprinting of skin tissues, further contributing to market growth.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Trade Analysis
Patent Analysis
Ecosystem of the Market
Customer & Buying Criteria Analysis
Regulatory Landscape
PESTEL Analysis
Innovation Matrix
Top Investment Analysis
Key Success Factor
Market Attractive Index
Degree of Competition

3D Bioprinting Market by Component

Market Overview
3D Bioprinters
- Micro Extrusion Bioprinters
- Inkjet 3D Bioprinters
- Laser-assisted Bioprinters
- Stereolithography-based Bioprinters
- Magnetic 3D Bioprinters
- Other
Bioinks
- Natural Bioinks
- Hybrid Bioinks
- Synthetic Bioinks
Software
Consumables

3D Bioprinting Market by Material

Market Overview
Living Cells
Hydrogels
Extracellular Matrices
Other

3D Bioprinting Market by Application

Market Overview
Research Applications
- Drug Research
- Regenerative Medicine
- 3D Cell Culture
Clinical Applications
- Skin
- Bone & Cartilage
- Blood Vessels
- Other

3D Bioprinting Market by Technology

Market Overview
Magnetic Levitation
Inkjet-based
Syringe-based
Laser-based
Others

3D Bioprinting Market by End User

Market Overview
Academic & Research Institutes
Pharmaceutical & Biotechnology Companies
Hospitals

3D Bioprinting Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- Italy
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Organovo Holdings, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
3D Systems, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CELLINK AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stratasys Ltd. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Rokit Healthcare (Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Poietis SAS (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aspect Biosystems Ltd. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cyfuse Biomedical K.K. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tissuelabs (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Advanced Solutions, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
RegenHU Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Materialise NV (Belgium)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Microdrop Technologies GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GeSiM mbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
3D Biotek, LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
REGEMAT 3D, SL (Spain)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
POIETIS (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SUNP BIOTECH (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MEDPRIN (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PRODWAYS (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments